BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. May 28, 2026; 32(20): 116036
Published online May 28, 2026. doi: 10.3748/wjg.v32.i20.116036
Table 3 Clinical end points, n (%)
Characteristics
Rhubarb group (n = 144)
Controls group (n = 140)
Primary end point
Death failure2 (1.39)4 (2.86)
Secondary end points
Gastrointestinal function restoration to tolerate enteral nutrition time (day)5 (4-9)8 (5-14)
Intraperitoneal hemorrhage3 (2.08)5 (3.57)
Upper gastrointestinal hemorrhage12 (8.33)23 (16.43)a
Deep venous thrombosis7 (4.86)21 (15.00)b
ICU stay (day)13 (7-16)18 (6-21)


Write to the Help Desk